Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

SynapDx Autism Gene Expression Analysis Study (STORY)
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
Status: Enrolling
Updated:  1/22/2014
Vanderbilt University
mi
from
Nashville, TN
SynapDx Autism Gene Expression Analysis Study (STORY)
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
Status: Enrolling
Updated: 1/22/2014
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
SynapDx Autism Gene Expression Analysis Study (STORY)
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
Status: Enrolling
Updated:  1/22/2014
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
SynapDx Autism Gene Expression Analysis Study (STORY)
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
Status: Enrolling
Updated: 1/22/2014
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
SynapDx Autism Gene Expression Analysis Study (STORY)
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
Status: Enrolling
Updated:  1/22/2014
Seattle Children's
mi
from
Seattle, WA
SynapDx Autism Gene Expression Analysis Study (STORY)
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
Status: Enrolling
Updated: 1/22/2014
Seattle Children's
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Jonesboro, AR
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Boynton Beach, FL
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
West Palm Beach, FL
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
New Orleans, LA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Detroit, MI
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Minneapolis, MN
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Birmingham, AL
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Phoenix, AZ
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
San Francisco, CA
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Stanford, CA
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Jacksonville, FL
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Miami, FL
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Tampa, FL
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Atlanta, GA
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Kansas City, KA
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Rochester, MN
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Lincoln, NE
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Hershey, PA
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Hershey, PA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Pittsburgh, PA
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Memphis, TN
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Dallas, TX
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
Houston, TX
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2014
Questcor Investigational Site
mi
from
San Antonio, TX
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2014
Questcor Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
North Central Neurology Associates, PC
mi
from
Cullman, AL
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
North Central Neurology Associates, PC
mi
from
Cullman, AL
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
University of Colorado Hospital, Aschutz Inpatient Pavilion
mi
from
Aurora, CO
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
University of Colorado Hospital, Aschutz Inpatient Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
Indiana University Health Neuroscience Center
mi
from
Indianapolis, IN
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
Indiana University Health Neuroscience Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
University of Kansas Medical Center
mi
from
Kansas City, KA
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
Beth Israel Deaconess Medical Center, Center for Life Sciences
mi
from
Boston, MA
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
Beth Israel Deaconess Medical Center, Center for Life Sciences
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
Wayne State University - University Health Center
mi
from
Detroit, MI
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
Wayne State University - University Health Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
MS Center of Northeastern NY/Empire Neurology
mi
from
Latham, NY
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
MS Center of Northeastern NY/Empire Neurology
mi
from
Latham, NY
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
Univ of Rochester Medical Center
mi
from
Rochester, NY
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
The Neurological Institute
mi
from
Charlotte, NC
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
The Neurological Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2014
Swedish Medical Center
mi
from
Seattle, WA
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2014
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Traditional African Healing Ceremony in a U.S. Population
Traditional African Healing Ceremony in a U.S. Population
Status: Enrolling
Updated:  2/5/2014
Duke University
mi
from
Durham, NC
Traditional African Healing Ceremony in a U.S. Population
Traditional African Healing Ceremony in a U.S. Population
Status: Enrolling
Updated: 2/5/2014
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Cellular and Molecular Kinetics of Cerebrospinal Fluid (CSF) Using Heavy Water Labeling Method: A Study of Healthy Controls, CNS HIV Infection, Parkinson's Disease and Other Neurodegenerative Diseases
Status: Enrolling
Updated:  2/6/2014
San Francisco General Hospital
mi
from
San Francisco, CA
Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Cellular and Molecular Kinetics of Cerebrospinal Fluid (CSF) Using Heavy Water Labeling Method: A Study of Healthy Controls, CNS HIV Infection, Parkinson's Disease and Other Neurodegenerative Diseases
Status: Enrolling
Updated: 2/6/2014
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Nelson Handal
mi
from
Dothan, AL
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Nelson Handal
mi
from
Dothan, AL
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Wen Cal
mi
from
Tucson, AZ
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Wen Cal
mi
from
Tucson, AZ
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Bernardo Ng
mi
from
Imperial, CA
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Bernardo Ng
mi
from
Imperial, CA
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Synergy Clinical Research Center
mi
from
National City, CA
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Synergy Clinical Research Center
mi
from
National City, CA
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Pacific Sleep Medicine, A Medical Corporation
mi
from
Oceanside, CA
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Pacific Sleep Medicine, A Medical Corporation
mi
from
Oceanside, CA
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Neuropsychiatric Research Center for Orange County
mi
from
Orange, CA
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Neuropsychiatric Research Center for Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  2/10/2014
Peninsula Research Associates, Inc.
mi
from
Rolling Hills Estates, CA
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 2/10/2014
Peninsula Research Associates, Inc.
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials